Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03088865
Other study ID # 0017-17-HMO
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date September 6, 2018

Study information

Verified date February 2020
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Implementation of the initial specimen diversion technique, in which the first milliliter of the venipuncture sample is not injected into the culture bottle, led to a significant reduction in blood culture contamination rates. This technique is based on the assumption that the skin plug aspirated during venipuncture is a major source of contaminating bacteria. One such diversion method is aspirating the first blood volume into a blood collection tube. It has, however, been suggested that regular blood collection tubes carry contaminants from the tube's stopper into the blood cultures drawn afterwards, thereby increasing contamination rates. The aim of this trial is to examine the effect of aspirating the first blood volume into a regular blood collection tube on blood culture contamination rate.


Recruitment information / eligibility

Status Completed
Enrollment 756
Est. completion date September 6, 2018
Est. primary completion date September 6, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults evaluated in the emergency room or as inpatients for suspected sepsis or having sepsis and from whom the treating physician plans to take, in the same venous puncture, blood cultures and additional blood tests (blood count and/or blood chemistry).

Exclusion Criteria:

- None

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
aspirating first blood volume into a regular blood collection tube
order of blood drawing

Locations

Country Name City State
Israel Hadassah Medical Center Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood culture contamination rate A blood culture contamination is defined as growth in a single set of coagulase-negative Staphylococcus, Micrococcus, Viridans group Streptococcus, Propionibacterium acne, Corynebacterium sp (diphtheroids) or Bacillus sp. 7 days
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04764058 - Efficacy and Safety of Colistin Based Antibiotic Therapy Phase 1/Phase 2
Completed NCT00046072 - A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis Phase 2
Completed NCT01520597 - National Study on Listeriosis and Listeria
Recruiting NCT03929159 - Correlating MicroRNA Changes With Sepsis Outcomes
Completed NCT03943719 - Clinical Impact of the FilmArray Blood Culture Identification Panel Performed on Positive Blood Cultures From Intensive Care Patients With Septicemia
Completed NCT00901940 - Understanding the Immune Response to Meningitis Vaccines Phase 3
Not yet recruiting NCT03583762 - Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique N/A
Completed NCT02988414 - Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
Completed NCT02102087 - Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device N/A
Recruiting NCT05045963 - Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
Terminated NCT02093494 - Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters N/A
Active, not recruiting NCT02069028 - Effectiveness of Different Interventions for Implementing Surviving Sepsis Campaign (SSC) Guidelines on Compliance and Mortality: Systematic Review and Meta-analysis N/A
Recruiting NCT00258869 - Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests N/A
Completed NCT05358912 - Efficacy of Targeted Abdominal Perfusion Pressure in Septic Shock Phase 4
Recruiting NCT05893420 - A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning N/A
Recruiting NCT05040503 - Monitoring Mitophagy In Myeloid Cells Upon Intensive Care N/A
Completed NCT00146432 - Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1) Phase 2/Phase 3
No longer available NCT04636554 - Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia